ESC Premium Access

An international multicenter clustered randomized trial to IMProve treatment with oral AntiCoagulanTs in Atrial Fibrilation

Congress Presentation

About the speaker

Professor Christopher B Granger

Duke University Medical Center, Durham (United States of America)
15 presentations
1 follower

17 more presentations in this session

SPYRAL HTN OFF-MED Study

Speaker: Professor M. Boehm (Homburg, DE)

Thumbnail

Discussant review: SPYRAL HTN OFF-MED Study

Speaker: Professor B. Williams (London, GB)

Thumbnail

Panel discussion.

Thumbnail

Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial

Speaker: Professor M. Ezekowitz (Philadelphia, US)

Thumbnail

Discussant review:Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial

Speaker: Professor J. Nielsen (Aarhus, DK)

Thumbnail

Access the full session

Hot Line: Late-Breaking Clinical Trials 2

Speakers: Professor C. Granger, Professor M. Boehm, Professor B. Williams, Professor M. Ezekowitz, Professor J. Nielsen
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk